Sandip Kumar Roy

3.4k citations
75 papers · 2.5k indexed · 2 hit papers · h-index 18

Impact in

  • Hematology top 5%
    • Acute Myeloid Leukemia Research
  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • CAR-T cell therapy research
    • Neutropenia and Cancer Infections

Papers in

Sandip Kumar Roy

71 papers receiving 2.4k citations

Hit Papers

Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. 2001 · 660 citations
6601998202620072016200400600

Peers

Sandip Kumar Roy
Comparison fields: 5 of 150
  • Hematology 324
  • Oncology 765
  • Pharmacology 189
  • Metals and Alloys 41
  • Molecular Biology 1.1k
Replace Shinichi Sato with:
Shinichi Sato Japan
Robert A. Kramer United States
William P. Petros United States
Kōichi Goto Japan
Simon Zhou United States
Steven Weitman United States
Massimo Zucchetti Italy
Marcel Rozencweig Belgium
Mark J. McKeage New Zealand
Joseph Ciccolini France
Sandip Kumar Roy relative to Shinichi Sato Japan Shinichi Sato's profile →
Citations per field
00.5×3.7×
Shinichi Sato · 1×
Citations per year

Countries citing papers authored by Sandip Kumar Roy

Since Specialization
Citations

This map shows the geographic impact of Sandip Kumar Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandip Kumar Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandip Kumar Roy more than expected).

Fields of papers citing papers by Sandip Kumar Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandip Kumar Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandip Kumar Roy. The network helps show where Sandip Kumar Roy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sandip Kumar Roy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandip Kumar Roy Line = papers co-authored together Sandip Kumar Roy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20243
4 20238
5 20212
6
A comparative study of saline and non-saline water in application of tomato yield by using photonic sensor
20161
7 201615
8 201511
9 201064
10 2008290
11 20067
12
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
Hit paper breakdown →
2001660
13 199868
14
Genetic basis for the glucuronidation of SN-38: Role of UGT*1 isoform
19973
15 199716
16 199615
17 199539
18 19947
19 199488
20 19782

About Sandip Kumar Roy

Sandip Kumar Roy is a scholar working on Electrical and Electronic Engineering, Metals and Alloys, Transplantation, Biophysics and Electrochemistry, having authored 75 papers that have together received 2.5k indexed citations. Recurring topics across this work include Corrosion Behavior and Inhibition (8 papers), Photonic and Optical Devices (7 papers), Electrodeposition and Electroless Coatings (7 papers), Catalytic Alkyne Reactions (5 papers), Semiconductor materials and devices (5 papers), Cyclization and Aryne Chemistry (5 papers), Photonic Crystals and Applications (5 papers) and DNA Repair Mechanisms (4 papers). The work is most often cited by research in Hematology (324 citations), Oncology (765 citations), Pharmacology (189 citations), Metals and Alloys (41 citations) and Molecular Biology (1.1k citations). Sandip Kumar Roy has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Srikumar Sahasranaman, Danny R. Howard, Mark J. Ratain, Thomas R. Tephly, Lalitha Iyer, Christopher D. King, Birgit L. Coffman, P. F. Whitington, Julie Beitz and Peter Bross. Their work appears in journals such as Chemical Communications, Drug Metabolism and Disposition, Biochemical Pharmacology, Applied Surface Science and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026